The results also illustrated the potential of a small field of high dose ionizing radiation combining with an immune checkpoint blockade agent, anti-PD-L1 antibody, for treating PDAC in an orthotopic murine pancreatic tumor model. Here, CD274 is linked to pancreatic neoplasm.